2021
DOI: 10.1007/s00775-021-01887-3
|View full text |Cite
|
Sign up to set email alerts
|

Cu (II)-porphyrin metal–organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 67 publications
0
24
0
Order By: Relevance
“… Scanning electron microscope (SEM) analysis for (A) GO, (B) Cu–TCPP MOF, and (C) CuG, respectively. Reproduced with permission 40 . Copyright 2021, Springer Nature.…”
Section: D P‐mofs Composites/derivativesmentioning
confidence: 99%
See 1 more Smart Citation
“… Scanning electron microscope (SEM) analysis for (A) GO, (B) Cu–TCPP MOF, and (C) CuG, respectively. Reproduced with permission 40 . Copyright 2021, Springer Nature.…”
Section: D P‐mofs Composites/derivativesmentioning
confidence: 99%
“…The functional groups on the base materials can combine with the metal sites of 2D p-MOFs to realize the optimization of the compostite properties. Zahra Gharehdaghi et al 40 proposed a method for synthesizing 2D Cu-TCPP MOF supported on graphene oxide (GO) nanosheets. Cu-TCPP was attached to GO through the interaction between epoxy groups on GO and metal sites (Figure 3).…”
Section: Growth Of 2d P-mofs On Other Materialsmentioning
confidence: 99%
“…Owing to their numerous advantages, Cu MOFs are suitable candidates for the development of nano-delivery platforms: I) they provide a unique broad-spectrum antibacterial effect ( Lee et al, 2021 ; Wang Z. et al, 2022 ); II) they possess the ability to stimulate endothelial cell proliferation and differentiation, thereby promoting angiogenesis by simulating hypoxia ( Dang et al, 2020 ); III) they possess an open skeleton framework and excellent chemical stability ( Liu et al, 2019 ); IV) they possess a unique near-infrared (NIR) absorption ability, which can be used to develop photo-thermal therapy (PTT) nano-drug system ( Weng et al, 2020 ; Wang L. et al, 2021 ; Geng et al, 2022 ); V) they have a favorable loading capacity and are a good choice for developing chemodynamic therapy (CDT) nanocarriers ( Hao et al, 2021b ). Recently, small-molecule drugs, such as chlorhexidine ( Soltani and Akhbari, 2022 ), DOX ( Gharehdaghi et al, 2021 ), 5-fluorouracil ( Liu W. et al, 2020 ), methotrexate ( Nezhad-Mokhtari et al, 2019 ), diclofenac sodium, chlorpromazine hydrochloride, amodiaquin dihydrochloride ( Liu et al, 2019 ), and ibuprofen ( Javanbakht et al, 2019 ), have been successfully loaded into nano-drug delivery systems through Cu MOFs. Enzymatically active molecules, such as horseradish peroxidase and glucose oxidase, can also be effectively loaded by Cu MOFs and exhibit superior stabilities than those in the free state ( Hao et al, 2021a ; Lin et al, 2021 ).…”
Section: Classification Of Mnpsmentioning
confidence: 99%
“…Another problem that restricts the use of MOFs in anti-HCC treatment is drug loading and drug release ( Gharehdaghi et al, 2021 ; Jiang et al, 2021 ). The drug loading and release properties of these nanodrug delivery platforms depend on both the structure of the MOFs and the properties of the loaded drugs.…”
Section: Challenges Of Mof In Cancer Treatmentmentioning
confidence: 99%